JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1998; 31:1561-1567
© 1998 by the American College of Cardiology Foundation
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Groot, E
Right arrow Articles by Bruschke, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Groot, E
Right arrow Articles by Bruschke, A.

B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS)

E de Groot, JW Jukema, AD Montauban van Swijndregt, AH Zwinderman, RG Ackerstaff, AF van der Steen, N Bom, KI Lie, and AV Bruschke

Interuniversity Cardiology Institute, Utrecht, The Netherlands.

OBJECTIVES: In this B-mode ultrasound study we assessed pravastatin treatment effects on carotid and femoral artery walls and investigated the correlations between the state and evolution of peripheral and coronary atherosclerosis. BACKGROUND: The Regression Growth Evaluation Statin Study (REGRESS) was an 11-center, 2-year, double-blind, placebo-controlled, prospective study of 885 men with coronary artery disease (CAD) (total cholesterol 4 to 8 mmol/liter). The study primarily investigated pravastatin treatment effects on the coronary lumen. This report focuses on the 255 patients who participated in the REGRESS ultrasound study. METHODS: Carotid and femoral artery walls were imaged at baseline and at 6, 12, 18 and 24 months. Pravastatin treatment effect was defined as the difference in progression of the combined intima-media thicknesses (IMT) between treatment groups. RESULTS: Pravastatin treatment effects were highly significant (combined IMT: p = 0.0085; combined far wall IMT: p < 0.0001; common femoral artery far wall IMT: p = 0.004). Correlations between the IMTs of the arterial wall segments ranged from -0.17 to 0.81. Baseline correlations between IMT and percent coronary lumen stenoses ranged from 0.23 to 0.36. Baseline IMT correlated with the mean coronary segment diameter (r = -0.32, p = 0.001) and minimal coronary obstruction diameter (r = -0.27, p = 0.005). There were no individual correlations between IMT and coronary lumen variables (p > 0.30). CONCLUSIONS: Pravastatin treatment effects on carotid and femoral artery walls were observed. B-mode ultrasound imaging studies of peripheral arterial walls could not describe the state and evolution of the coronary lumen in the individual patient, but proved to be a highly suitable tool for the assessment of antiatherosclerotic properties of agents.


This article has been cited by other articles:


Home page
J Ultrasound MedHome page
M. Egger, A. Krasinski, B. K. Rutt, A. Fenster, and G. Parraga
Comparison of B-Mode Ultrasound, 3-Dimensional Ultrasound, and Magnetic Resonance Imaging Measurements of Carotid Atherosclerosis
J. Ultrasound Med., September 1, 2008; 27(9): 1321 - 1334.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
B. V. Howard, M. J. Roman, R. B. Devereux, J. L. Fleg, J. M. Galloway, J. A. Henderson, Wm. J. Howard, E. T. Lee, M. Mete, B. Poolaw, et al.
Effect of Lower Targets for Blood Pressure and LDL Cholesterol on Atherosclerosis in Diabetes: The SANDS Randomized Trial
JAMA, April 9, 2008; 299(14): 1678 - 1689.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. J.P. Kastelein, F. Akdim, E. S.G. Stroes, A. H. Zwinderman, M. L. Bots, A. F.H. Stalenhoef, F. L.J. Visseren, E. J.G. Sijbrands, M. D. Trip, E. A. Stein, et al.
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
N. Engl. J. Med., April 3, 2008; 358(14): 1431 - 1443.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. F. Drager, L. A. Bortolotto, A. C. Figueiredo, E. M. Krieger, and G. Lorenzi-Filho
Effects of Continuous Positive Airway Pressure on Early Signs of Atherosclerosis in Obstructive Sleep Apnea
Am. J. Respir. Crit. Care Med., October 1, 2007; 176(7): 706 - 712.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
S. S. DeLoach and E. R. Mohler III
Peripheral Arterial Disease: A Guide for Nephrologists
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 839 - 846.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. J.P. Kastelein, S. I. van Leuven, L. Burgess, G. W. Evans, J. A. Kuivenhoven, P. J. Barter, J. H. Revkin, D. E. Grobbee, W. A. Riley, C. L. Shear, et al.
Effect of Torcetrapib on Carotid Atherosclerosis in Familial Hypercholesterolemia
N. Engl. J. Med., April 19, 2007; 356(16): 1620 - 1630.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
R. J. Bisoendial, J. J. P. Kastelein, S. L. M. Peters, J. H. M. Levels, R. Birjmohun, J. I. Rotmans, D. Hartman, J. C. M. Meijers, M. Levi, and E. S. G. Stroes
Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects
J. Lipid Res., April 1, 2007; 48(4): 952 - 960.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. R. Crouse III, J. S. Raichlen, W. A. Riley, G. W. Evans, M. K. Palmer, D. H. O'Leary, D. E. Grobbee, M. L. Bots, and for the METEOR Study Group
Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals With Subclinical Atherosclerosis: The METEOR Trial
JAMA, March 28, 2007; 297(12): 1344 - 1353.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J. H. Revkin, C. L. Shear, H. G. Pouleur, S. W. Ryder, and D. G. Orloff
Biomarkers in the Prevention and Treatment of Atherosclerosis: Need, Validation, and Future
Pharmacol. Rev., March 1, 2007; 59(1): 40 - 53.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. R. Crouse III
Thematic review series: Patient-Oriented Research. Imaging atherosclerosis: state of the art
J. Lipid Res., August 1, 2006; 47(8): 1677 - 1699.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. R.S. Fernandes, J. F. Polak, T. Edvardsen, B. Carvalho, A. Gomes, D. A. Bluemke, K. Nasir, D. H. O'Leary, and J. A.C. Lima
Subclinical Atherosclerosis and Incipient Regional Myocardial Dysfunction in Asymptomatic Individuals: The Multi-Ethnic Study of Atherosclerosis (MESA)
J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2420 - 2428.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
V. Aboyans, J. Guilloux, P. Lacroix, C. Yildiz, A. Postil, and M. Laskar
Common carotid intima-media thickness measurement is not a pertinent predictor for secondary cardiovascular events after coronary bypass surgery. A prospective study
Eur. J. Cardiothorac. Surg., September 1, 2005; 28(3): 415 - 419.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. K. Hovingh, B. A. Hutten, A. G. Holleboom, W. Petersen, P. Rol, A. Stalenhoef, A. H. Zwinderman, E. de Groot, J. J.P. Kastelein MD, and J. A. Kuivenhoven
Compromised LCAT Function Is Associated With Increased Atherosclerosis
Circulation, August 9, 2005; 112(6): 879 - 884.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. L. Higgins, S. A. Marvel, and J. D. Morrisett
Quantification of Calcification in Atherosclerotic Lesions
Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1567 - 1576.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
K de Leeuw, J-S Sanders, C Stegeman, A Smit, C G Kallenberg, and M Bijl
Accelerated atherosclerosis in patients with Wegener's granulomatosis
Ann Rheum Dis, May 1, 2005; 64(5): 753 - 759.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Yonemura, Y. Momiyama, Z. A. Fayad, M. Ayaori, R. Ohmori, K. Higashi, T. Kihara, S. Sawada, N. Iwamoto, M. Ogura, et al.
Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging
J. Am. Coll. Cardiol., March 1, 2005; 45(5): 733 - 742.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
F. W. Asselbergs, A. M. van Roon, H. L. Hillege, P. E. de Jong, R. O.B. Gans, A. J. Smit, W. H. van Gilst, and on behalf of the PREVEND IT Investigators
Effects of Fosinopril and Pravastatin on Carotid Intima-Media Thickness in Subjects With Increased Albuminuria
Stroke, March 1, 2005; 36(3): 649 - 653.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. Amarenco, J. Labreuche, P. Lavallee, and P.-J. Touboul
Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis
Stroke, December 1, 2004; 35(12): 2902 - 2909.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. A.C. Lima, M. Y. Desai, H. Steen, W. P. Warren, S. Gautam, and S. Lai
Statin-Induced Cholesterol Lowering and Plaque Regression After 6 Months of Magnetic Resonance Imaging-Monitored Therapy
Circulation, October 19, 2004; 110(16): 2336 - 2341.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Alonso-Villaverde, B. Coll, S. Parra, M. Montero, N. Calvo, M. Tous, J. Joven, and L. Masana
Atherosclerosis in Patients Infected With HIV Is Influenced by a Mutant Monocyte Chemoattractant Protein-1 Allele
Circulation, October 12, 2004; 110(15): 2204 - 2209.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. K. Hovingh, A. Brownlie, R. J. Bisoendial, M. P. Dube, J. H.M. Levels, W. Petersen, R. P.F. Dullaart, E. S.G. Stroes, A. H. Zwinderman, E. de Groot, et al.
A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease
J. Am. Coll. Cardiol., October 6, 2004; 44(7): 1429 - 1435.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. de Groot, G. K. Hovingh, A. Wiegman, P. Duriez, A. J. Smit, J.-C. Fruchart, and J. J.P. Kastelein
Measurement of Arterial Wall Thickness as a Surrogate Marker for Atherosclerosis
Circulation, June 15, 2004; 109(23_suppl_1): III-33 - III-38.
[Abstract] [Full Text]


Home page
Vasc MedHome page
P. Poredos
Intima-media thickness: indicator of cardiovascular risk and measure of the extent of atherosclerosis
Vascular Medicine, February 1, 2004; 9(1): 46 - 54.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
E. M. Tuzcu and P. Schoenhagen
Acute coronary syndromes, plaque vulnerability,and carotid artery disease: The changing role ofatherosclerosis imaging
J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1033 - 1036.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
P. R. W. de Sauvage Nolting, E. de Groot, A. H. Zwinderman, R. J. A. Buirma, M. D. Trip, and J. J. P. Kastelein
Regression of Carotid and Femoral Artery Intima-Media Thickness in Familial Hypercholesterolemia: Treatment With Simvastatin
Arch Intern Med, August 11, 2003; 163(15): 1837 - 1841.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. G. Lakatta and D. Levy
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises: Part I: Aging Arteries: A "Set Up" for Vascular Disease
Circulation, January 7, 2003; 107(1): 139 - 146.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
K.-S. Cheng, D. P. Mikhailidis, G. Hamilton, and A. M. Seifalian
A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors
Cardiovasc Res, June 1, 2002; 54(3): 528 - 538.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Jartti, T. Ronnemaa, J. Kaprio, M.J. Jarvisalo, J.O. Toikka, J. Marniemi, N. Hammar, L. Alfredsson, M. Saraste, J. Hartiala, et al.
Population-Based Twin Study of the Effects of Migration From Finland to Sweden on Endothelial Function and Intima-Media Thickness
Arterioscler. Thromb. Vasc. Biol., May 1, 2002; 22(5): 832 - 837.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
Y. Arai, N. Hirose, K. Yamamura, M. Kimura, A. Murayama, I. Fujii, and M. Tsushima
Long-Term Effect of Lipid-Lowering Therapy on Atherosclerosis of Abdominal Aorta in Patients with Hypercholesterolemia: Noninvasive Evaluation by a New Image Analysis Program
Angiology, January 1, 2002; 53(1): 57 - 68.
[Abstract] [PDF]


Home page
Circ. Res.Home page
Z. A. Fayad and V. Fuster
Clinical Imaging of the High-Risk or Vulnerable Atherosclerotic Plaque
Circ. Res., August 17, 2001; 89(4): 305 - 316.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
C. M Nass, J. K Allen, R. M Jermyn, and L. A Fleisher
Secondary prevention of coronary artery disease in patients undergoing elective surgery for peripheral arterial disease
Vascular Medicine, February 1, 2001; 6(1): 35 - 41.
[Abstract] [PDF]


Home page
CirculationHome page
J. Hsia, J. A. Simon, F. Lin, W. B. Applegate, M. T. Vogt, D. Hunninghake, and M. Carr
Peripheral Arterial Disease in Randomized Trial of Estrogen With Progestin in Women With Coronary Heart Disease : The Heart and Estrogen/Progestin Replacement Study
Circulation, October 31, 2000; 102(18): 2228 - 2232.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. S. Forrester, C. N. Bairey-Merz, and S. Kaul
The aggressive low density lipoprotein lowering controversy
J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1419 - 1425.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Hulthe, L. Bokemark, J. Wikstrand, and B. Fagerberg
The Metabolic Syndrome, LDL Particle Size, and Atherosclerosis : The Atherosclerosis and Insulin Resistance (AIR) Study
Arterioscler. Thromb. Vasc. Biol., September 1, 2000; 20(9): 2140 - 2147.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. Baldassarre, E. Tremoli, M. Amato, F. Veglia, A. Bondioli, and C. R. Sirtori
Reproducibility Validation Study Comparing Analog and Digital Imaging Technologies for the Measurement of Intima-Media Thickness
Stroke, May 1, 2000; 31(5): 1104 - 1110.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
B. J. Ansell, K. E. Watson, and A. M. Fogelman
An Evidence-Based Assessment of the NCEP Adult Treatment Panel II Guidelines
JAMA, December 1, 1999; 282(21): 2051 - 2057.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1998 by the American College of Cardiology Foundation.